C8937 – Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)

Long description

Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)

Short description

Cad breast mri

Pricing indicator

53 Statute

Medicare coverage

D Special coverage instructions apply

BETOS category

I2D Advanced imaging - MRI/MRA: other

Cross reference

0159T

Added

January 1, 2019

Last change

January 1, 2019 – No change

Nearby C codes

• C8929 – Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography
• C8930 – Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision
• C8931 – Magnetic resonance angiography with contrast, spinal canal and contents
• C8932 – Magnetic resonance angiography without contrast, spinal canal and contents
• C8933 – Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents
• C8934 – Magnetic resonance angiography with contrast, upper extremity
• C8935 – Magnetic resonance angiography without contrast, upper extremity
• C8936 – Magnetic resonance angiography without contrast followed by with contrast, upper extremity
• C8957 – Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump
• C9014 – Injection, cerliponase alfa, 1 mg
• C9015 – Injection, c-1 esterase inhibitor (human), haegarda, 10 units
• C9016 – Injection, triptorelin extended release, 3.75 mg
• C9021 – Injection, obinutuzumab, 10 mg
• C9022 – Injection, elosulfase alfa, 1mg
• C9023 – Injection, testosterone undecanoate, 1 mg
• C9024 – Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine